Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 342

Results For "UST"

3935 News Found

USAID announces Momentum country programme
Public Health | November 15, 2021

USAID announces Momentum country programme

The initiative will engage adolescents and youth of India in decisions about their reproductive health


Sparsh opens super speciality hospital for women and children in Bangalore
Hospitals | November 15, 2021

Sparsh opens super speciality hospital for women and children in Bangalore

The 50-bed hospital is positioned to address complexities specific to women and children, going beyond a birthing facility


Tripura CM inaugurates advanced imaging facility at Niramay Health centre
Medical Device | November 15, 2021

Tripura CM inaugurates advanced imaging facility at Niramay Health centre

Carestream equipment is highly recommended for its imaging quality


Jubilant HollisterStier plans US $92 mn expansion
News | November 13, 2021

Jubilant HollisterStier plans US $92 mn expansion

The 50,000 square foot expansion will house a high-speed filling line and lyophilizers, which will increase the facility’s sterile injectable capacity by 50%


European Commission approves Ronapreve to treat Covid-19
Drug Approval | November 13, 2021

European Commission approves Ronapreve to treat Covid-19

Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus


Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22
News | November 13, 2021

Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22

Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021


World’s first Whole Genome Sequencing study uncovers new and potential therapies
News | November 12, 2021

World’s first Whole Genome Sequencing study uncovers new and potential therapies

The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families


Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients
Biotech | November 12, 2021

Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients

A final decision regarding the approval of Ronapreve is expected from the European Commission shortly


Covaxin well tolerated with no safety concerns: Lancet
News | November 12, 2021

Covaxin well tolerated with no safety concerns: Lancet

Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%


Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
News | November 12, 2021

Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22

Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.